Derleme
PDF Mendeley EndNote BibTex Kaynak Göster

Feline fibroepithelial hyperplasia and current treatment protocols

Yıl 2022, Cilt 6, Sayı 1, 18 - 25, 30.04.2022
https://doi.org/10.30704/http-www-jivs-net.1031677

Öz

Due to prolonged exposure to daylight, the seasonal oestrus cycle in cats has reached the point where it can spread almost throughout the year. This situation has brought many problems with it. Mammary tumors and mammary gland hyperplasia are the most common conditions in mammary tissue as a result of exogenous progesterone applications for reproductive control. In this review, information about the etiology, pathogenesis, clinical detection and especially current and successful treatment options for mammary gland hyperplasia in cats is given.

Kaynakça

  • Allen, H. L. (1973). Feline mammary hypertrophy. Veterinary pathology, 10(6), 501-508.
  • Amorim, F. V. (2007). Hiperplasia mamária felina. Acta Scientiae Veterinariae, 35(2), 279-280.
  • Bethlehem, M.,& Van Der Luer, R. J. (1993). Felinefibro-epithelial hyperplasia in 3 castrated tom cats following treatment with progestagens. Tijdschriftvoordiergeneeskunde, 118(20), 650-652.
  • Burstyn, U. (2010). Management of mastitis and abscessation of mammary glands secondary to fibroadenomatous hyperplasia in a primiparturientcat. Journal of the American Veterinary Medical Association, 236(3), 326-329.
  • Concannon, P. W., & Myers-Wallen, V. N. (1991). Current and proposed methods for contraception and termination of pregnancy in dogsandcats. Journal of the American Veterinary Medical Association, 198(7), 1214-1225.
  • Conneely, O. M., Mulac-Jericevic, B., &Lydon, J. P. (2003). Progesterone-dependentregulation of female reproductive activity by two distinct progesterone receptor isoforms. Steroids, 68(10-13), 771-778.
  • De Las Mulas, J. M., Millan, Y., Bautista, M. J., Perez, J., & Carrasco, L. (2000). Oestrogen and progesterone receptors in feline fibroadenomatous change: an immunohistochemical study. Research in Veterinary Science, 68(1), 15-21.
  • De Melo, E. H.,Câmara, D. R., Notomi, M. K., Jabour, F. F., Garrido, R. A., Nogueira, A. C., & de Souza, F. W. (2021). Effectiveness of ovariohysterectomy on feline mammary fibroepithelial hyperplasia treatment. Journal of Feline Medicine and Surgery, 23(4), 351-356.
  • Enginler, S. O., Şenünver, A. (2011). The effects of progesterone hormone applications used for suppression of estrus on mammary glands in queens. Journal of Faculty of Veterinary Medicine, Kafkas University, 17(2), 277-284.
  • Gaviria, E. F. B.,Bonilla, D. E., & Gómez, A. L. (2010). Hiperplasia fibroepitelial mamaria felina: reporte de un caso. CES Medicina Veterinaria Zootecnia, 5(1), 70-76. Giménez, F.,Hecht, S., Craig, L. E., & Legendre, A. M. (2010). Early detection, aggressive therapy: optimizing the management of feline mammary masses. Journal of feline medicine and surgery, 12(3), 214-224.
  • Görlinger, S., Kooistra, H. S., Van den Broek, A., & Okkens, A. C. (2002). Treatment of fibroadenomatous hyperplasia in cats with aglepristone. Journal of veterinaryinternalmedicine, 16(6), 710-713.
  • Gultiken, N. (2016). Mammary Disease.Turkiye Klinikleri Veterinary Sciences-Obstetrics and Gynecology Special Topics, 2(2),102-108.
  • Habermehl, K. H. (1984). The skin and cutaneous organs. Lehrbuch der Anatomie der Haustiere. III. Kreislaufsystem, Haut und Hautorgane, (Ed. 2), 453-584.
  • Hayden, D. W., Johnston, S. D., Kiang, D. T., Johnson, K. H., &Barnes, D. M. (1981). Feline mammary hypertrophy / fibroadenoma complex: clinical and hormonal aspects. American journal of veterinary research, 42(10), 1699-1703.
  • Hinton, M., & Gaskell, C. J. (1977). Non-neoplastic mammary hypertrophy in the cat associatede ither with pregnancy or with oral progestagen therapy. The Veterinary Record, 100(14), 277-280.
  • Johnston, S. D., Kustritz, M. V. R., & Olson, P. N. S. (2001). Mammary hypertropy. Canine and feline theriogenology. Philadelphia, PA: Saunders.
  • Jurka, P., & Max, A. (2009). Treatment of fibroadenomatosis in 14 cats with aglepristone–changes in blood parameters and follow‐up. Veterinary Record, 165(22), 657-660.
  • Keskin, A., Yılmazbaş, G., Şimşek, G., & İntaş, K. S. (2008). Mammary hyperplasia in a pregnant queen. Australian Veterinary Practitoner, 38, 75.
  • Küçükbekir, Ç. N., Uçmak, Z. G., Kırşan, İ., & Tek, Ç. (2020). A case of feline fibroepithelial hyperplasia in a male cat. Journal of Istanbul Veterinary Sciences, 4(1), 8-12.
  • Lana, S. E., Rutteman, G. R., & Withrow, S. J. (2007). Tumors of the mammary gland. In Withrow & Mac Ewen's small animal clinical oncology (pp. 619-636). WB Saunders.
  • Leidinger, E., Hooijberg, E., Sick, K., Reinelt, B., & Kirtz, G. (2011). Fibroepithelial hyperplasia in an entire male cat: cytologic and histopathological features. Tierärztlich ePraxisAusgabe K: Kleintiere/Heimtiere, 39(03),198-202.
  • Little S. (2011). Feline reproduction: common problems you will see in practice. Proceedings of the 63rd Canadian Veterinary Medical Association Convention. Halifax, Nova Scotia, Canada.
  • Loretti, A. P., Ilha, M. R. S., Breitsameter, I., & Faraca, C. S. (2004). Clinical and pathological study of feline mammary fibroadenomatous change associated with depotmedroxyprogesterone acetatet herapy. Arquivo Brasilero de Medicina Veterinariae Zootecnia, 56(2), 270-274.
  • Loretti, A. P.,Ilha, M. R., Ordas, J., & Martin de lasMulas, J. (2005). Clinical, pathological and immunohistochemical study of feline mammary fibroepithelial hyperplasia following a single injection of depotmedroxyprogesterone acetate. Journal of Feline Medicine Surgery, 7, 43–52.
  • MacDougall, L. D. (2003). Mammary fibroadenomatous hyperplasia in a young cat attributed to treatment with megestrol acetate. Canadian Veterinary Journal, 44, 227-229.
  • Mayayo, S. L., Bo, S., &Pisu, M. C. (2018). Mammary fibroadenomatous hyperplasia in a male cat. Journal of Feline Medicine and Surgery Open Reports, 4(1). 2055116918760155.
  • Medeiros, M. G.; Motheo, T. F.; Voorwald, F. A.; Martins, D. G.; Toniollo, G. H.; Vicente, W. R. R. Hiperplasia fibroadenomatosa mamária felina e maceração fetal secundárias a administração de progestágenos. Acta Scientiae Veterinariae, Porto Alegre, v. 35, supl. 2, p. 656-657, 2007.
  • Mol, J. A., Gracanin, A., de Gier, J., Rao, N., Schaefers-Okkens, A., Rutteman, G., & Kooistra, H. (2012). Molecular genetics and biology of progesterone signaling in mammary neoplasia. In Proceedings of the joint meeting of the 7th International Symposium on Canine and Feline Reproduction and the 15th Congress of the European Veterinary Society for Small Animal Reproduction (pp. 107-108).
  • Motta, M. A. A., & Silveira, M. F. (2009). Hiperplasia fibroepitelial mamária feline: acompanhamento clínico de paciente ao longo de quarto anos. MEDVEP. Rev. cient. Med. Vet., 362-365.
  • Murphy, S. (2009). Mammary tumours in cats–causes and practical management. In Conference proceedings of theEuropeanSociety of Feline Medicine-ESFM Feline Symposium, 1st April (pp. 11-15).
  • Nak, D., Nak, Y., İntaş, K. S., & Kumru, İ. H. (2004). Treatment of feline mammary fibroadenomatous hyperplasia with aglepristone. Australian Veterinary Practitoner, 34(4), 161-162.
  • Ordás, J., Millán, Y., de losMonteros, A. E., Reymundo, C., & de Las Mulas, J. M. (2004). Immunohistochemical expression of progesterone receptors, growth hormone and insülin growth factor-I in feline fibroadenomatous change. Research in Veterinary Science, 76(3), 227–233.
  • Owen LN. (1979). A comparative study of canine and human breast cancer. Investigative & Cell Pathology 2(4), 257-275.
  • Ozenc, E., & Bozkurt, M. F. (2014). Atypical fibroepithelial hyperplasia of the teats in a Sphynx cat: a case report. Veterinární Medicína, 59(5), 265-269.
  • Payan-Carreira, R. (2013). Feline mammary fibroepithelial hyperplasia: a clinical approach. Insights fromVeterinaryMedicine, Ch-8.
  • Pereira, P. D., Carvalheira, J., & Gärtner, F. (2004). Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue – an immunohistochemical study. The Veterinary Journal, 168(2), 180-185.
  • Romagnoli, S., & Concannon, P. W. (2003). Clinicaluse of progestins in bitchesandqueens: a review. Recent advances in small animal reproduction. International Veterinary Information Service, Ithaca NY.
  • Seixas Travassos, M. A. (2006). Feline mammary lesions: a contributeto its biopathological characterization. portuguese. PhDthesis, Univ. de Trás-os-Montes e Alto Douro, 194.
  • Silva, F. B. Utilização de aglepristone no tratamento da hiperplasia mamária felina: relato de casos. 2008. 37f. Monografia (Graduação em Medicina Veterinária) – Escola de Medicina Veterinária, Universidade Federal da Bahia, SalvadorBA.
  • Solano-Gallego, L., & Masserdotti, C. (2016). Reproductive system. Canine and Feline Cytology, 313.
  • Sontas, B. H., Turna, Ö., Ucmak, M., &Ekici, H. (2008). What is your diagnosis? Journal of Small Animal Practice, 49(10), 545-547.
  • Sorenmo, K. U. (2011). Mammary gland tumors in cats: Risk factors, clinical presentation, treatments and outcome. In Proceedings of the 36th World Small AnimalVeterinaryCongress, Jeju (Korea), 14, 764-767.
  • Souza, T. M. D., Fighera, R. A., Langohr, I. M., &Barros, C. S. L. D. (2002). Hiperplasia fibroepitelial mamária em felinos: cincocasos. Ciência Rural, 32, 891-894.
  • Uçmak, M., Enginler, S. Ö., Gündüz, M. C., Kirşan, I. & Sönmez, K. (2011). Treatment of feline mammary fibroepithelial hyperplasia with the combination of aglepristone and cabergoline. Journal of Faculty of Veterinary Medicine, Istanbul University, 37(1), 69-73.
  • Vasconcellos, C. H. C. Hiperplasia mamária. In: Souza, H. J. M. Coletâneas em medicina e cirurgia felina. Rio de Janeiro: L. F. livros de veterinária, 2003. p. 231-237.
  • Vitasek, R., & Dendisova, H. (2006). Treatment of feline mammary fibroepithelial hyperplasia following a single injection of proligestone. Acta Veterinaria Brno, 75(2), 295-297.
  • Warner MR. (1976). Age incidence and site distribution of mammary dysplasiasis in young beagle bitches. Journal of National Cancer Institute. 57, 57-61.
  • Wehrend, A., Hospes, R., & Gruber, A. D. (2001). Treatment of feline mammary fibroadenomatous hyperplasia with aprogesterone-antagonist. Veterinary Records, 148, 346-347.

Feline fibroepithelial hyperplasia and current treatment protocols

Yıl 2022, Cilt 6, Sayı 1, 18 - 25, 30.04.2022
https://doi.org/10.30704/http-www-jivs-net.1031677

Öz

Nowadays, with the changing climatic conditions due to global warming, the seasonal estrus cycle in cats has reached the point where it can spread almost throughout the year. This situation has brought many problems with it. Mammary tumors and mammary gland hyperplasia are the most common cases in mammarytissue, which occur as a result of medical interventions for reproductive control. In this review, information about the etiology, pathogenesis and clinical detectionandespecially current and succeed treatment options of mammary gland hyperplasia in cats is given.

Kaynakça

  • Allen, H. L. (1973). Feline mammary hypertrophy. Veterinary pathology, 10(6), 501-508.
  • Amorim, F. V. (2007). Hiperplasia mamária felina. Acta Scientiae Veterinariae, 35(2), 279-280.
  • Bethlehem, M.,& Van Der Luer, R. J. (1993). Felinefibro-epithelial hyperplasia in 3 castrated tom cats following treatment with progestagens. Tijdschriftvoordiergeneeskunde, 118(20), 650-652.
  • Burstyn, U. (2010). Management of mastitis and abscessation of mammary glands secondary to fibroadenomatous hyperplasia in a primiparturientcat. Journal of the American Veterinary Medical Association, 236(3), 326-329.
  • Concannon, P. W., & Myers-Wallen, V. N. (1991). Current and proposed methods for contraception and termination of pregnancy in dogsandcats. Journal of the American Veterinary Medical Association, 198(7), 1214-1225.
  • Conneely, O. M., Mulac-Jericevic, B., &Lydon, J. P. (2003). Progesterone-dependentregulation of female reproductive activity by two distinct progesterone receptor isoforms. Steroids, 68(10-13), 771-778.
  • De Las Mulas, J. M., Millan, Y., Bautista, M. J., Perez, J., & Carrasco, L. (2000). Oestrogen and progesterone receptors in feline fibroadenomatous change: an immunohistochemical study. Research in Veterinary Science, 68(1), 15-21.
  • De Melo, E. H.,Câmara, D. R., Notomi, M. K., Jabour, F. F., Garrido, R. A., Nogueira, A. C., & de Souza, F. W. (2021). Effectiveness of ovariohysterectomy on feline mammary fibroepithelial hyperplasia treatment. Journal of Feline Medicine and Surgery, 23(4), 351-356.
  • Enginler, S. O., Şenünver, A. (2011). The effects of progesterone hormone applications used for suppression of estrus on mammary glands in queens. Journal of Faculty of Veterinary Medicine, Kafkas University, 17(2), 277-284.
  • Gaviria, E. F. B.,Bonilla, D. E., & Gómez, A. L. (2010). Hiperplasia fibroepitelial mamaria felina: reporte de un caso. CES Medicina Veterinaria Zootecnia, 5(1), 70-76. Giménez, F.,Hecht, S., Craig, L. E., & Legendre, A. M. (2010). Early detection, aggressive therapy: optimizing the management of feline mammary masses. Journal of feline medicine and surgery, 12(3), 214-224.
  • Görlinger, S., Kooistra, H. S., Van den Broek, A., & Okkens, A. C. (2002). Treatment of fibroadenomatous hyperplasia in cats with aglepristone. Journal of veterinaryinternalmedicine, 16(6), 710-713.
  • Gultiken, N. (2016). Mammary Disease.Turkiye Klinikleri Veterinary Sciences-Obstetrics and Gynecology Special Topics, 2(2),102-108.
  • Habermehl, K. H. (1984). The skin and cutaneous organs. Lehrbuch der Anatomie der Haustiere. III. Kreislaufsystem, Haut und Hautorgane, (Ed. 2), 453-584.
  • Hayden, D. W., Johnston, S. D., Kiang, D. T., Johnson, K. H., &Barnes, D. M. (1981). Feline mammary hypertrophy / fibroadenoma complex: clinical and hormonal aspects. American journal of veterinary research, 42(10), 1699-1703.
  • Hinton, M., & Gaskell, C. J. (1977). Non-neoplastic mammary hypertrophy in the cat associatede ither with pregnancy or with oral progestagen therapy. The Veterinary Record, 100(14), 277-280.
  • Johnston, S. D., Kustritz, M. V. R., & Olson, P. N. S. (2001). Mammary hypertropy. Canine and feline theriogenology. Philadelphia, PA: Saunders.
  • Jurka, P., & Max, A. (2009). Treatment of fibroadenomatosis in 14 cats with aglepristone–changes in blood parameters and follow‐up. Veterinary Record, 165(22), 657-660.
  • Keskin, A., Yılmazbaş, G., Şimşek, G., & İntaş, K. S. (2008). Mammary hyperplasia in a pregnant queen. Australian Veterinary Practitoner, 38, 75.
  • Küçükbekir, Ç. N., Uçmak, Z. G., Kırşan, İ., & Tek, Ç. (2020). A case of feline fibroepithelial hyperplasia in a male cat. Journal of Istanbul Veterinary Sciences, 4(1), 8-12.
  • Lana, S. E., Rutteman, G. R., & Withrow, S. J. (2007). Tumors of the mammary gland. In Withrow & Mac Ewen's small animal clinical oncology (pp. 619-636). WB Saunders.
  • Leidinger, E., Hooijberg, E., Sick, K., Reinelt, B., & Kirtz, G. (2011). Fibroepithelial hyperplasia in an entire male cat: cytologic and histopathological features. Tierärztlich ePraxisAusgabe K: Kleintiere/Heimtiere, 39(03),198-202.
  • Little S. (2011). Feline reproduction: common problems you will see in practice. Proceedings of the 63rd Canadian Veterinary Medical Association Convention. Halifax, Nova Scotia, Canada.
  • Loretti, A. P., Ilha, M. R. S., Breitsameter, I., & Faraca, C. S. (2004). Clinical and pathological study of feline mammary fibroadenomatous change associated with depotmedroxyprogesterone acetatet herapy. Arquivo Brasilero de Medicina Veterinariae Zootecnia, 56(2), 270-274.
  • Loretti, A. P.,Ilha, M. R., Ordas, J., & Martin de lasMulas, J. (2005). Clinical, pathological and immunohistochemical study of feline mammary fibroepithelial hyperplasia following a single injection of depotmedroxyprogesterone acetate. Journal of Feline Medicine Surgery, 7, 43–52.
  • MacDougall, L. D. (2003). Mammary fibroadenomatous hyperplasia in a young cat attributed to treatment with megestrol acetate. Canadian Veterinary Journal, 44, 227-229.
  • Mayayo, S. L., Bo, S., &Pisu, M. C. (2018). Mammary fibroadenomatous hyperplasia in a male cat. Journal of Feline Medicine and Surgery Open Reports, 4(1). 2055116918760155.
  • Medeiros, M. G.; Motheo, T. F.; Voorwald, F. A.; Martins, D. G.; Toniollo, G. H.; Vicente, W. R. R. Hiperplasia fibroadenomatosa mamária felina e maceração fetal secundárias a administração de progestágenos. Acta Scientiae Veterinariae, Porto Alegre, v. 35, supl. 2, p. 656-657, 2007.
  • Mol, J. A., Gracanin, A., de Gier, J., Rao, N., Schaefers-Okkens, A., Rutteman, G., & Kooistra, H. (2012). Molecular genetics and biology of progesterone signaling in mammary neoplasia. In Proceedings of the joint meeting of the 7th International Symposium on Canine and Feline Reproduction and the 15th Congress of the European Veterinary Society for Small Animal Reproduction (pp. 107-108).
  • Motta, M. A. A., & Silveira, M. F. (2009). Hiperplasia fibroepitelial mamária feline: acompanhamento clínico de paciente ao longo de quarto anos. MEDVEP. Rev. cient. Med. Vet., 362-365.
  • Murphy, S. (2009). Mammary tumours in cats–causes and practical management. In Conference proceedings of theEuropeanSociety of Feline Medicine-ESFM Feline Symposium, 1st April (pp. 11-15).
  • Nak, D., Nak, Y., İntaş, K. S., & Kumru, İ. H. (2004). Treatment of feline mammary fibroadenomatous hyperplasia with aglepristone. Australian Veterinary Practitoner, 34(4), 161-162.
  • Ordás, J., Millán, Y., de losMonteros, A. E., Reymundo, C., & de Las Mulas, J. M. (2004). Immunohistochemical expression of progesterone receptors, growth hormone and insülin growth factor-I in feline fibroadenomatous change. Research in Veterinary Science, 76(3), 227–233.
  • Owen LN. (1979). A comparative study of canine and human breast cancer. Investigative & Cell Pathology 2(4), 257-275.
  • Ozenc, E., & Bozkurt, M. F. (2014). Atypical fibroepithelial hyperplasia of the teats in a Sphynx cat: a case report. Veterinární Medicína, 59(5), 265-269.
  • Payan-Carreira, R. (2013). Feline mammary fibroepithelial hyperplasia: a clinical approach. Insights fromVeterinaryMedicine, Ch-8.
  • Pereira, P. D., Carvalheira, J., & Gärtner, F. (2004). Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue – an immunohistochemical study. The Veterinary Journal, 168(2), 180-185.
  • Romagnoli, S., & Concannon, P. W. (2003). Clinicaluse of progestins in bitchesandqueens: a review. Recent advances in small animal reproduction. International Veterinary Information Service, Ithaca NY.
  • Seixas Travassos, M. A. (2006). Feline mammary lesions: a contributeto its biopathological characterization. portuguese. PhDthesis, Univ. de Trás-os-Montes e Alto Douro, 194.
  • Silva, F. B. Utilização de aglepristone no tratamento da hiperplasia mamária felina: relato de casos. 2008. 37f. Monografia (Graduação em Medicina Veterinária) – Escola de Medicina Veterinária, Universidade Federal da Bahia, SalvadorBA.
  • Solano-Gallego, L., & Masserdotti, C. (2016). Reproductive system. Canine and Feline Cytology, 313.
  • Sontas, B. H., Turna, Ö., Ucmak, M., &Ekici, H. (2008). What is your diagnosis? Journal of Small Animal Practice, 49(10), 545-547.
  • Sorenmo, K. U. (2011). Mammary gland tumors in cats: Risk factors, clinical presentation, treatments and outcome. In Proceedings of the 36th World Small AnimalVeterinaryCongress, Jeju (Korea), 14, 764-767.
  • Souza, T. M. D., Fighera, R. A., Langohr, I. M., &Barros, C. S. L. D. (2002). Hiperplasia fibroepitelial mamária em felinos: cincocasos. Ciência Rural, 32, 891-894.
  • Uçmak, M., Enginler, S. Ö., Gündüz, M. C., Kirşan, I. & Sönmez, K. (2011). Treatment of feline mammary fibroepithelial hyperplasia with the combination of aglepristone and cabergoline. Journal of Faculty of Veterinary Medicine, Istanbul University, 37(1), 69-73.
  • Vasconcellos, C. H. C. Hiperplasia mamária. In: Souza, H. J. M. Coletâneas em medicina e cirurgia felina. Rio de Janeiro: L. F. livros de veterinária, 2003. p. 231-237.
  • Vitasek, R., & Dendisova, H. (2006). Treatment of feline mammary fibroepithelial hyperplasia following a single injection of proligestone. Acta Veterinaria Brno, 75(2), 295-297.
  • Warner MR. (1976). Age incidence and site distribution of mammary dysplasiasis in young beagle bitches. Journal of National Cancer Institute. 57, 57-61.
  • Wehrend, A., Hospes, R., & Gruber, A. D. (2001). Treatment of feline mammary fibroadenomatous hyperplasia with aprogesterone-antagonist. Veterinary Records, 148, 346-347.

Ayrıntılar

Birincil Dil İngilizce
Konular Veteriner Hekimlik
Bölüm Derleme Makaleler
Yazarlar

Hülya KULA
ISTANBUL UNIVERSITY-CERRAHPASA, INSTITUTE OF GRADUATE PROGRAMS
0000-0002-7402-086X
Türkiye


Zeynep GÜNAY UÇMAK (Sorumlu Yazar)
Istanbul University-Cerrahpaşa, Faculty of Veterinary Medicine, Department of Obstetrics and Gynaecology, Istanbul, Turkey
0000-0003-2530-1291
Türkiye

Yayımlanma Tarihi 30 Nisan 2022
Yayınlandığı Sayı Yıl 2022, Cilt 6, Sayı 1

Kaynak Göster

APA Kula, H. & Günay Uçmak, Z. (2022). Feline fibroepithelial hyperplasia and current treatment protocols . Journal of Istanbul Veterinary Sciences , 6 (1) , 18-25 . DOI: 10.30704/http-www-jivs-net.1031677

Bu dergi Creative Commons attribution 4.0 international  (CC-BY 4.0). lisansı ile lisanslanmıştır.